Latest Market News

Ryman Healthcare’s FY26 retirement living sales hit 1,410 ORAs, aligning with guidance despite a Q4 dip in new sales. The company reports robust aged care occupancy and expects free cash flow near NZD 180 million.

Yancoal Australia is set to acquire an 80% stake in the Kestrel Coal Mine for US$1.85 billion upfront plus up to US$550 million in contingent payments, significantly boosting its metallurgical coal portfolio and production scale in Queensland.

BlackRock Investment Management has announced estimated cash distributions for its Australian iShares Balanced ESG and High Growth ESG ETFs, with key dates set for mid to late April 2026. Investors have until 15 April to opt into the Distribution Reinvestment Plan.

Telix Pharmaceuticals has initiated a US$550 million convertible bonds offering to refinance existing 2029 bonds and support general corporate purposes, securing low-cost, non-dilutive financing with a conversion premium above current share price.

Rhythm Biosciences has clarified inconsistencies in its disclosures around termination events in its underwriting agreement for RHYO options, following an ASX query. The company acknowledged an incomplete initial summary and administrative oversights but confirmed the agreement remains in full effect.

The Qualitas Real Estate Income Fund (ASX: QRI) has raised its March 2026 distribution yield to 7.25% annualised, reflecting a completed investment loan on assets needing repositioning amid ongoing high interest rates.

Tian An Australia Limited reported a statutory profit of $23.4 million for the year ended 31 December 2025, driven by strong property development sales and a gain from restructuring its major shareholder loan. The company progressed multiple residential projects and improved its net asset position amid a recovering housing market.

Lifestyle Communities reported a moderation in new home sales in Q3 FY26 due to economic uncertainty but achieved strong nine-month sales growth and significant inventory reduction, lowering net debt substantially.

Tarrina Resources (ASX: TR8) has addressed ASX’s query on recent share price movement, confirming it has dispatched soil and drill core samples for laboratory testing with results expected by late April. The company maintains strict confidentiality protocols and affirms compliance with continuous disclosure rules.

New Hope Corporation has updated its dividend details, confirming a fully franked 10 cents per share interim payout for FY2026 and setting the Dividend Reinvestment Plan price at $5.41 with no discount.

Percheron Therapeutics has closed a $2.2 million entitlement offer to advance its HMBD-002 immuno-oncology candidate towards a phase II trial in 2026, backed by strong shareholder and new investor support.

Cue Energy Resources has reinforced its call for shareholders to reject Horizon Oil’s takeover bid, citing a new multi-year gas sales agreement and planned well drilling at Palm Valley that underpin its long-term revenue growth.